atorvastatin has been researched along with End Stage Liver Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, ML; Bendtsen, F; Gantzel, RH; Gao, Q; Grønbæk, H; Hobolth, L; Kimer, N; Kronborg, TM; Moritz, T; Møller, S; Schierwagen, R; Teisner, AS; Trebicka, J; Trošt, K | 1 |
1 trial(s) available for atorvastatin and End Stage Liver Disease
| Article | Year |
|---|---|
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial.
Topics: Anti-Inflammatory Agents; Atorvastatin; End Stage Liver Disease; Humans; Hypertension, Portal; Liver Cirrhosis; Severity of Illness Index | 2023 |